Rocket


News + Filings
Transactions





All
All (ex-4s)
10-K
10-Q
8-K
3,4,5
Proxy
Prospectus
Other



Martin Steven Robert Create: Alert

All | News | Filings
Date FiledTypeDescription
06/27/2022 4 Form 4 - Statement of changes in beneficial ownership of securities:
02/04/2022 4 Martin Steven Robert (Director) has filed a Form 4 on Ensysce Biosciences, Inc.
Txns: Granted 20,000 options to buy @ $3.13, valued at $62.6k
07/02/2021 4 Form 4 - Statement of changes in beneficial ownership of securities:
03/26/2021 4 Form 4 - Statement of changes in beneficial ownership of securities:
12/09/2020 4 Martin Steven Robert (CFO) has filed a Form 4 on Armata Pharmaceuticals, Inc.
Txns: Granted 23,000 options to buy @ $3.15, valued at $72.5k
05/24/2019 4 Martin Steven Robert (CFO) has filed a Form 4 on Armata Pharmaceuticals, Inc.
Txns: Granted 149,362 options to buy @ $3.15, valued at $470.5k
09/11/2017 4 Form 4 - Statement of changes in beneficial ownership of securities:
04/04/2017 4 Form 4 - Statement of changes in beneficial ownership of securities
12/13/2016 4 Form 4 - Statement of changes in beneficial ownership of securities
01/20/2016 4 Martin Steven Robert (CFO) has filed a Form 4 on AmpliPhi Biosciences Corp
Txns: Granted 99,919 options to buy @ $2.85, valued at $284.8k
02/24/2014 4 Form 4 - Statement of changes in beneficial ownership of securities
02/10/2014 4 Martin Steven Robert (Senior VP & CFO) has filed a Form 4 on APRICUS BIOSCIENCES, INC.
Txns: Granted 75,000 options to buy @ $2.36, valued at $177k
05/24/2013 4 Martin Steven Robert (Senior VP & CFO) has filed a Form 4 on APRICUS BIOSCIENCES, INC.
Txns: Bought 20,000 shares @ $2.85, valued at $57k
Bought 20,000 warrants @ $3.4, valued at $68k
04/01/2013 4 Martin Steven Robert (Senior VP & CFO) has filed a Form 4 on APRICUS BIOSCIENCES, INC.
Txns: Granted 1,371 options to buy @ $2.68, valued at $3.7k
02/28/2013 4 Form 4 - Statement of changes in beneficial ownership of securities
12/20/2012 4 Martin Steven Robert (Interim CEO and CFO) has filed a Form 4 on APRICUS BIOSCIENCES, INC.
Txns: Granted 75,000 options to buy @ $2.035, valued at $152.6k
11/30/2012 4 Martin Steven Robert (Interim CEO & CFO) has filed a Form 4 on APRICUS BIOSCIENCES, INC.
Txns: Granted 2,083 options to buy @ $2.2, valued at $4.6k
03/07/2012 4 Martin Steven Robert (CFO) has filed a Form 4 on APRICUS BIOSCIENCES, INC.
Txns: Granted 195,000 options to buy @ $3.23, valued at $629.9k
06/06/2011 4 Martin Steven Robert (CFO) has filed a Form 4 on APRICUS BIOSCIENCES, INC.
Txns: Granted 150,000 options @ $5.02, valued at $753k
03/04/2010 4 Form 4 - Statement of changes in beneficial ownership of securities

Rocket Data Systems, Inc. © 2019 | Contact Us | Data Disclaimer | Terms of Use | Privacy